Copyright © 2015 Wiley Periodicals Inc.
Edited By: Thomas Murphy
Impact Factor: 2.297
ISI Journal Citation Reports © Ranking: 2013: 28/118 (Pediatrics); 31/54 (Respiratory System)
Online ISSN: 1099-0496
- SCOPE OF JOURNAL
- AUTHOR RESOURCES
- ENGLISH LANGUAGE SERVICES
- ELECTRONIC SUBMISSION OF MANUSCRIPTS
- MANUSCRIPT GUIDELINES
- PRIOR TO SUBMITTING
- COMPONENTS OF ARTICLES/FILE PREPARATION
- POLICIES/DISCLOSURE STATEMENTS
- PEER REVIEW PROCESS
- FAST TRACK REVIEW
- SUBMISSIONS FROM EDITORS AND EDITORIAL BOARD MEMBERS
- AUTHOR CHARGES
- MANUSCRIPTS ACCEPTED FOR PUBLICATION
- APPEALS PROCESS
- PRODUCTION QUESTIONS
- QUESTIONS ABOUT YOUR SUBMISSION
- CONTACT THE EDITOR-IN-CHIEF
Pediatric Pulmonology publishes the results of original clinical or laboratory research, state of the art reviews, exceptionally instructive or unique case reports, and letters to the Editor (and responses), pertaining to the specialty.
Reports on meetings, conferences and symposia may be published after consultation with the Publisher and the Editor-in-Chief.
Preliminary brief communications will be considered if the articles contain information which would be considered a major breakthrough in the field.
We do not publish research funded by tobacco companies.
As the field is continually evolving, our Journal has seen an increase in the number of submissions over the past few years, and, as a result, our rejection rate is climbing.
No material published in Pediatric Pulmonology may be reproduced or published elsewhere without the written permission of the publisher and the author. To request permission to reproduce an article, in part, or in whole, click here to for the Permissions Page
For additional tools visit Author Services - an enhanced suite of online tools for WileyOnlineLibary journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.
The Editors reserve the right to return any manuscript that is not in acceptable English. Translations from another language will not be provided by the Editorial Office. Authors from countries in which English is not the primary language should have their manuscript reviewed and corrected by an English language service before submission. To read more about our policy, and to view a list of editing services, visit: http://authorservices.wiley.com/bauthor/english_language.asp
If you are familiar with our guidelines, click here to login to your ScholarOne account to submit your manuscript. If you do not have an account, click on “Register Here” to establish one.
We accept submissions of the following types of articles. Please note the specific guidelines for each type:
Original Research Articles should follow the standard structure of abstract, introduction, methods, results, discussion, and references, and may include up to six tables and/or images when appropriate. Original Research Articles should be limited to 3,500 words (not including the abstract or references). The abstract should not exceed 250 words, and references should be limited to forty (40).
Editors generally commission Reviews and State of the Art papers, but uninvited submissions are also welcome, particularly if the submission outlines an important and topical subject with a focus on recent advances. Reviews should be limited to 4,000 words, while State of the Art papers should be limited to 5,000 words (not including the abstract or references). We ask that the abstracts for these manuscript types do not exceed 250 words. There is no set limit on images, tables, or references for these types of manuscripts.
Case reports should be concise (a maximum of 1,000 words, not including the abstract or references), and contain a maximum of two images and/or tables. The summary/abstract should not exceed 100 words. Case Reports should contain no more than five (5) references. Authorship of case reports shall be limited to three (3). Physicians who participated in the care, but did not contribute to the writing of the manuscript may be listed under acknowledgements. Informed consent must be documented. Authors should note that most accepted Case Reports will be published online only, and not in a print edition.
Editors and members of the Editorial Board may make editorial comments on individual articles or on a group of articles published in the same issue. Editorials (including pro/con debates) from authors who are not part of the editorial team are also welcome as submissions to the Journal. These narrowly focused articles should discuss an article that was recently published, or that is soon to be published. The commentary should discuss specific issues within a subject area rather than the whole field, while explaining the implications of the article and putting it in context. Opinions must be factually based. These types of manuscripts should be limited to 1,500 words (not including the abstract or references). There is no limitation on the number of tables, images or references for these types of manuscripts.
We encourage letters that offer criticism of published material in an objective, constructive, and educational manner conducive to further exchanges. Such letters will only be considered if they are in reference to an article published within the previous six months. Letters may also discuss matters of general interest pertaining to the field of pediatric pulmonology, or may consist of brief reports of truly unique cases. Note that we do not publish original, previously unpublished data as letters. If appropriate, a copy will be sent to the author(s) referred to in the letter, so that they may respond. Letters to the Editor should not exceed 1,000 words (not including the abstract or references), and may contain a small table or single image. Letters should contain no more than five (5) references.
Prior to submitting a manuscript through ScholarOne, prepare the text and images according to the instructions found below. You may enter and exit the manuscript submission process at the completion of each step, and you may save an unfinished draft in the system to work on later. However, once you submit your manuscript though the system, you will not be able to access it for editing. If you have any questions about this process please contact us at email@example.com
We recommend all authors familiarize themselves with the International Committee of Medical Journal Editors: Uniform Requirements for Manuscripts submitted to Biomedical Journals. Ann Intern Med 1997;126:36-47. The complete text of the document be found online at www.icmje.org
Please make note of the following when preparing your submission:
All manuscript types must include a title page, abstract, text and references in the Main Document. Standard, double-spaced manuscript format, in 12 point font is requested. Number all pages consecutively.
Title page: The title should be brief (no more than 100 characters in length including spaces) and useful for indexing. All authors’ names with highest academic degree, affiliation of each, but no position or rank, should be listed. For cooperative studies, the institution where research was primarily done should be indicated. In a separate paragraph, specify grants, other financial support received, and the granting institutions (grant number(s) and contact name(s) should be indicated on the title page). If support from manufacturers of products used is listed, assurances about the absence of bias by the sponsor and principal author must be given. Identify meetings, if any, at which the paper was presented. The name, complete mailing address, telephone number, fax number, and e-mail address of the person to whom correspondence and reprint requests are to be sent must be included. Keywords should also be noted on the title page. For usage as a running head, provide an abbreviated title (maximum 50 characters) on the bottom of the title page.
Summary/Abstract: In accordance with the structure of the article, with or without separate headings, outline the objectives, working hypothesis, study design, patient-subject selection, methodology, results (including numerical findings) and conclusions. The Summary should not exceed the word counts outlined above. If abbreviations are used several times, spell out the words followed by the abbreviations in parentheses.
Acknowledgements: Technical assistance, advice, referral of patients, etc. may be briefly acknowledged at the end of the text under “Acknowledgements.”
Informed Consent: Informed consent statements, if applicable, should be included in the Methods section.
References/citations: References may be included at the end of your text, or uploaded as a separate file. Ensure your references are up to date, and include a critical selection from the world literature. References should be prepared according to CSE (Council of Science Editors) citation-sequence style. Refer to the Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, 8th edition (University of Chicago Press). Start the listing on a new page, double-spaced throughout.
Number the references in the sequence in which they first appear in the text, listing each only once even though it may be cited repeatedly.
When citing a reference in the text, the style advocated by CSE suggests numbers appear in superscript, and appear before punctuation marks (commas or periods). In the citation-sequence system, sources are numbered by order of reference so that the first reference cited in the paper is 1, the second 2, and so on. If the numbers are not in a continuous sequence, use commas (with no spaces) between numbers. If you have more than two numbers in a continuous sequence, use the first and last number of the sequence joined by a hyphen, for example 2,4,6-10.
In the references, list the first ten authors of the cited paper. If there are more than ten authors, list the first 10 authors followed by 'et al'.
Journals’ names should be shown by their abbreviated title in Index Medicus.
Manuscripts in preparation or submitted for publication are not acceptable references. If a manuscript “in press” is used as a reference, a copy of it must be provided with your submission.
Standard journal article
Landau IL, Morgan W, McCoy KS, Taussig LM. Gender related differences in airway tone in children. Pediatr Pulmonol 1993;16:31-35.
Book with authors
Voet D, Voet JG. 1990. Biochemistry. New York: John Wiley & Sons. 1223 p.
Book with editors
Coutinho A, Kazatch Kine MD, editors. Autoimmunity physiology and disease. New York. Wiley-Liss; 1994. 459 p.
Chapter from a book
Hausdorf G. Late effects of anthracycline therapy in childhood: evaluation and current therapy. In: Bricker JT, Green DM, D'Angio GJ, editors. Cardiac toxicology after treatment for childhood cancer. New York: Wiley-Liss; 1993. p 73-86.
For a book reference only include the page numbers that have direct bearing on the work described.
Keywords: On the title page, supply a minimum of 3 to 5 keywords, exclusive of words in the title of the manuscript. A guide to medical subject heading terms used by PubMed is available at http://www.nlm.nih.gov/mesh/MBrowser.html
Abbreviations: Define abbreviations when they first occur in the manuscript and from there on use only the abbreviation. Whenever standardized abbreviations are available use those. Use standard symbols with subscripts and superscripts in their proper place.
Drug names: Use generic names. If identification of a brand name is required, insert it in parentheses together with the manufacturer’s name and address after the first mention of the generic name.
Eponyms: Eponyms (diseases or biologic entities named for persons) should not be used when standard descriptive terminology is available. Examples include club cells (formerly known as Clara cells); and granulomatosis with polyangiitis (formerly known as Wegener’s granulomatosis). It is permissible to use the eponym in parenthesis at the first mention of the term in cases in which the eponym is still in common use.
Formatting Specific to Original Research Articles: Divide article into: Title Page, Summary/Abstract, Introduction, Materials and Methods, Results, Discussion, and References, starting each section on a new page. All methodology and description of experimental subjects should be under Materials and Methods; results should not be included in the Introduction. Please ensure the following appears in the appropriate section of your manuscript:
- a concise introductory statement outlining the specific aims of the study and providing a discussion of how each aim was fulfilled;
- a succinct description of the working hypothesis;
- a detailed explanation of assumptions and choices made regarding study design and methodology;
- a description of the reasons for choosing the type and number of experimental subjects (patients, animals, controls) and individual measurements; if applicable, information about how and why the numbers may differ from an ideal design (e.g., the number required for achieving 90% confidence in eliminating Type II error);
- specifics about statistical principles, techniques and calculations employed and, if applicable, methods for rejecting the null hypothesis;
- a concise comparison of the results with those of conflicting or confirmatory studies in the literature;
- a brief summary of the limitations of the scientific methods and results; and
- a brief discussion of the implications of the findings for the field and for future studies.
Tables should not be included in the Main Document, but submitted as a separate DOC or RTF file. Number tables with Arabic numbers consecutively and in order of appearance. Type each table double-spaced on a separate page, captions typed above the tabular material. Symbols for units should be used only in column headings. Do not use internal horizontal or vertical lines; place horizontal lines between table caption and column heading, under column headings, and at the bottom of the table (above the footnotes if any). Use footnote letters (a, b, c, etc.) in consistent order in each table. All tables should be referred to in the text. Do not submit tables as photographs and do not separate legends from tables.
Image files must be submitted in TIF or EPS (with preview) formats. Do not embed images in the Main Document. Number images with Arabic numbers and refer to each image in the text. The preferred form is 5 X 7 inches (12.5 X 17.5 cm). Print reproduction requires files for full color images to be in a CMYK color space.
Please note authors are encouraged to supply color images regardless of whether or not they are amenable to paying the color reproduction fees. Color images will be published online, while greyscale versions will appear in print at no charge to the author. See Author Charges below.
Journal quality reproduction requires grey scale and color files at resolutions yielding approximately 300 ppi. Bitmapped line art should be submitted at resolutions yielding 600-1200 ppi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.
Lettering on images should be of a size and weight appropriate to the content and the clarity of printing must allow for legibility after reduction to final size. Labeling and arrows on images must be done professionally. Spelling, abbreviations, and symbols should precisely correspond to those used in the text. Indicate the stain and magnification of each photomicrograph. Photographs of recognizable subjects must be accompanied by signed consent of the subject of publication. Images previously published must be accompanied by the author’s and publisher’s permission.
Image legends should be brief, and included as a separate DOC file under the heading: “Image Legends.” When borrowed material is used, the source of the image should be shown in parentheses after its legend, either by a reference number or in full if not listed under References.
Additional non-essential material such as text, appendices, tables, images, video, and soundtrack files may be submitted for posting as supporting information to an article. The scientific value of such material should be evident. The material should be submitted simultaneously with the manuscript so that it may undergo peer review. In naming these files, please note the file names should be preceded by the letter “E.” For example “E-table 1,“E-image 1,” “E-text,” etc.
Note that supporting online material is not typeset, nor proofread following the review process, so please ensure the material is accurate and free of typographical errors. Supporting material should be prepared in the same manner as the print material.
While supporting information does not appear in the print version, a notation is made that supporting material is available online.Top of Page
We recognize the importance of developing the highest ethical standards and we are committed to ethical publication practice. For more information on the publisher’s policies, please see Wiley-Blackwell Guidelines on Publication Ethics and Best Practices www.wiley.com/bw/publicationethics. Of particular importance is the section on Research Misconduct, which includes data fabrication, falsification, plagiarism, and inappropriate image manipulation.
Authors who submit to Pediatric Pulmonology should take heed of the following:
Conflict of Interest: Authors must indicate at the time of submission any potential conflict of interest (particularly of a fiscal nature) that may have a perceived influence on the results of the research. The existence of such does not automatically preclude publication. A conflict of interest statement should appear in the Acknowledgment section. For further information on Conflict of Interest please visit www.icjme.org
Experimental and Publication Ethics: Studies involving human subjects must conform to the guiding principles of the World Medical Association Declaration of Helsinki. Human subjects must have given informed consent and the study must have been approved by the Committee on Human Research at the author(s) institution(s) and a statement to this effect must appear in the Methods section of the submitted article. It is also important to document in the Methods section that consent has been obtained from older children and adolescents. Similarly, animal studies must be approved by an Institutional Animal Research Review Board and a statement to this effect must appear in the Methods section. In addition, details of anesthesia and euthanasia must appear in the Methods section.
Plagiarism: It should be noted that Pediatric Pulmonology employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works. CrossCheck is a multi-publisher initiative to screen published and submitted content for originality. Pediatric Pulmonology uses iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. To find out more about CrossCheck visit http://www.crossref.org/crosscheck.html.
Prior Publication: Manuscripts submitted to Pediatric Pulmonology may not have been published in any part or form in another publication of any type, professional or lay, including electronic publications, the exception being abstracts of no more than 400 words. Any material available via PubMed or other electronic sources is considered to have been published. When a question arises, the Editor-in-Chief will determine what constitutes duplicate publication. If duplicate publication is confirmed, the Editor-in-Chief will initiate a discussion with the sponsoring institution and the authors.
It is the responsibility of submitting authors to inform the Editor-in-Chief of potentially overlapping or related data either in submitted manuscripts or papers in press, and such manuscripts should be appended to the submission. If there is significant overlap in data with previously published articles this should be addressed by the author in the “Authors Comments” section during the submission process. In particular, giving reasons why the new submission should be published. The editors reserve the right to determine whether or not publication is warranted.
For further information on redundant or duplicate publication, please visit http://www.icmje.org
Clinical Trials: We endorse the Consolidated Statement of Reporting Trials (CONSORT Statement) Lancet 2002;357:1191-1194 which may be accessed at www.consort-statement.org. In accordance with ICMJE standards, all clinical trials must be registered with a database that is publicly accessible such as http://clinicaltrials.gov/ However, other free of charge public registries are acceptable. For further information, please visit http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/
Upon submission, authors are encouraged to submit names of experts who they deem appropriate to review their paper. Authors may also indicate persons to whom they do not wish the manuscript sent for review. In most cases, articles will be reviewed by at least two authorities as well as the editorial staff to determine validity, significance, novelty, and potential impact on the field of contents and conclusions. The reviewers will be selected by the Editor-in-Chief, Associate Editors, and/or Editorial Board members. The selection will be made on the basis of expertise, impartiality, and equal distribution among the available experts, regardless of geographic origin of the manuscript or locations of the reviewers. Authors will be advised within the shortest possible time whether their paper is accepted, requires major or minor revisions, or is rejected. All necessary efforts will be made to ensure a timely review process.
Authors should note the time from submission to final decision can be shortened by a timely return of a revised manuscript when revision has been requested.
The Editor-in-Chief reserves the right to reject any submission deemed not suitable for the journal after an in-house review.
If circumstances so warrant, a fast-track review of a paper may be requested in the cover letter. At the Editor-in-Chief’s discretion, a fast-track review will be undertaken to expedite manuscripts that deserve rapid review and publication. Expedited peer review and publication is rare and is reserved for timely presentation of significant data. If fast-track review is requested in the cover letter, the corresponding author will be informed if expedited review has been granted or not.
Pediatric Pulmonology strives to ensure that any submission from the Editor-in-Chief, Deputy Editor, the Associate Editors, or from a member of the journal’s Editorial Board receives an objective and unbiased evaluation. This is achieved by assigning any research article submitted by the Editor-in-Chief, Deputy or Associate Editors to an impartial referee who can maintain the integrity of the review process. When appropriate, Pediatric Pulmonology may also utilize the services of Guest Editors who are familiar with the peer review processes and policies of the journal. Articles submitted by Editorial Board members undergo a blinded peer review process that is as stringent as for those authors who are not on the Board. All submitting authors are automatically blinded to all aspects of the review process.
Should authors wish for manuscript images appear in color in the print edition, color reproduction fees will be charged to the authors. Current color reproduction fees are: one page $950 US, two pages $1450 US, three pages $1950 US. Authors do, however, have the option of submitting color images for online publication, and greyscale images for the print edition at no charge, and we encourage authors to do so. For information on color charges, please contact Production Editor, at ppulprod @wwiley.com
The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services where via the Wiley Author Licensing Service (WALS) they will be able to complete a license agreement on behalf of all authors on the paper:
OnlineOpen fulfills RCUK, Wellcome Trust, NIH, and other funder mandates. Authors can use OnlineOpen to make their article open access and freely available to all on Wiley Online Library. Wiley also immediately deposit OnlineOpen articles in PubMed Central and PMC mirror sites. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication.
With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access.
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Note to NIH Grantees: Pursuant to the NIH mandate, Wiley Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see Wiley Blackwell’s NIH Policy Statement.
If the OnlineOpen option is not selected, the corresponding author will be presented with the copyright transfer agreement (CTA) to sign on behalf of all authors.
To preview the terms and conditions of the open access agreements, or the copyright transfer agreement, please visit the FAQs hosted on Wiley Author Services. See http://authorservices.wiley.com/bauthor/faqs_copyright.asp and http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
Following acceptance, the corresponding author will be alerted by e-mail to access galley proofs in web-based proofing system. Corrections should be returned within 48 hours of receipt, as delays in returning galley proofs cause delays in publication. Alterations should be kept to a minimum. Costs of extensive alterations to the galley proof will be billed to the authors. All statements in (or omissions from) published manuscripts are the responsibility of the authors who are asked to carefully review proofs prior to publication.
Reprints may be ordered at: https://caesar.sheridan.com/reprints/eorder/order
Authors who wish to request reconsideration of a rejected manuscript should direct their query to the Editor in Chief, Tom Murhpy, firstname.lastname@example.org or Managing Editor, Carlene Rummery, at email@example.com. Requests must include the manuscript ID and a detailed description of why the authors believe the paper should be reconsidered.
Appeal requests will be evaluated by the Editor-in-Chief to determine if an appeal will be permitted. These appeals will be approved on a very limited basis. If the appeal is allowed, instructions will be provided on how to resubmit your paper. Authors should not resubmit their rejected paper without prior approval from the Editors and the Editorial Office. Requests that are sent elsewhere will not be considered.
Contact Production Editor at firstname.lastname@example.org
Contact Carlene Rummery, Managing Editor at email@example.com
Thomas Murphy, firstname.lastname@example.orgTop of Page